ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LUPIN NEWS why is Lupin Limited price falling or rising

LUPIN NEWS reasons for why stock price of Lupin Limited is falling or rising

LUPIN Lupin is falling or rising technical reasons

Technical analysis forecast of Lupin Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Lupin LUPIN at this time. Stock is rising and might rise more.

It appears as if Lupin LUPIN gave a large move recently.

Stock of Lupin (LUPIN) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.

My analysis of Lupin is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 2112.7 as stoploss in an intra day sell trade for a target of 2091.41. However, stock will show a bullish move above 2112.7.

LUPIN Lupin is falling or rising NEWS fundamental reasons

Company Announcement Lupin Limited has informed the Exchange about an update on acquisition of VISUfarma B.V., the Netherlands. - NEWS as on 2025-12-30

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated December 29, 2025, titled "Lupin Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist". - NEWS as on 2025-12-30

Company Announcement Lupin Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 - NEWS as on 2025-12-26

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated December 18, 2025, titled "Lupin Signs Exclusive Licensing Agreement with Neopharmed for Gastroenterology - NEWS as on 2025-12-18

Lupin inks licensing pact with Neopharmed for Plasil brand in Philippines, Brazil Pharma major Lupin Limited has secured exclusive marketing rights for the gastroenterology brand Plasil in the Philippines and Brazil. Subsidiaries in these nations inked a deal with Italy's Neopharmed Gentili S.p.A. This move will boost Lupin's gastroente - NEWS as on 2025-12-18 indiatimes.com

Company Announcement Lupin Limited has informed the Exchange regarding the receipt of Establishment Inspection Report (EIR) by the Company from the U.S. FDA for its injectables facility in Nagpur, India, vide Press Release dated December 16, 2025. - NEWS as on 2025-12-17

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated December 16, 2025, titled "Lupin Secures SBTi Validation for Emission Reduction Targets". - NEWS as on 2025-12-16

Company Announcement - NEWS as on 2025-12-11

Company Announcement Lupin Limited has informed the Exchange regarding Allotment of 36626 Shares. - NEWS as on 2025-12-10

Company Announcement Lupin Limited has informed the Exchange about ESG Rating by NSE Sustainability Ratings & Analytics Limited. - NEWS as on 2025-12-10

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated December 05, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Siponimod Tablets". - NEWS as on 2025-12-05

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated December 04, 2025, titled "Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg (Pegfilgrastim-unne) in the United States". - NEWS as on 2025-12-04

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated December 01, 2025, titled "Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg (Pegfilgrastim-unne)". - NEWS as on 2025-12-01

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated November 28, 2025, titled "Lupin Foundation Earns CRISIL s Highest VO 1A Rating for Excellence in Social Responsibility". - NEWS as on 2025-11-28

More announcements and NEWS

LUPIN Lupin Limited current price & indicator signals

Moving Averages for Lupin Limited

  • 5Day Average: 2098.28
  • 12Day Average: 2106.03
  • 20Day Average: 2095.85
  • 50Day Average: 2040.28
  • 100Day Average: 1999.5
  • 150Day Average: 1982.54
  • 200Day Average: 1993.26

LUPIN Indicators & signals

Indicator MACD (12,26,9)

2099.57, 2083.54, 20.72
Indicator MACD is in positive zone

Indicator ADX (14)

10.26, 21.9, 17.82
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LUPIN Lupin Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
31 Wed Dec 2025 2109.50 2077.80 to 2115.70 1.4% 0.92 times
30 Tue Dec 2025 2080.40 2065.10 to 2098.80 -0.08% 2.44 times
29 Mon Dec 2025 2082.10 2078.10 to 2114.00 -1.43% 0.91 times
26 Fri Dec 2025 2112.40 2095.70 to 2117.00 0.26% 1.41 times
24 Wed Dec 2025 2107.00 2096.20 to 2115.00 -0.31% 0.68 times
23 Tue Dec 2025 2113.50 2103.50 to 2131.80 -0.6% 0.3 times
22 Mon Dec 2025 2126.30 2116.60 to 2138.70 0.02% 0.68 times
19 Fri Dec 2025 2125.80 2111.10 to 2146.90 0.32% 0.85 times
18 Thu Dec 2025 2119.10 2098.00 to 2127.10 0.28% 0.74 times
17 Wed Dec 2025 2113.10 2095.90 to 2128.00 1.08% 1.12 times
16 Tue Dec 2025 2090.60 2077.60 to 2099.90 -0.1% 0.86 times
15 Mon Dec 2025 2092.60 2086.40 to 2121.90 -1.01% 0.7 times

Videos related to: LUPIN NEWS why is Lupin Limited price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

LUPIN NEWS why is Lupin Limited price falling or rising

 

Back to top